Position in DYN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,130,000
-$83,034,320 QoQ
Shares Held
1,000,000
-80.7% QoQ
Ownership
0.700%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,579,664,431 across 120 Biotechnology names. DYN ranks #51 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,475,611 | $532,503,169 | |
| 2 | RPRX |
Royalty Pharma plc
|
7,480,633 | $358,845,965 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
8,925,010 | $354,501,397 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
12,794,097 | $354,396,486 | |
| 5 | TNGX |
Tango Therapeutics, Inc.
|
12,809,485 | $267,974,426 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
815,739 | $262,822,948 | |
| 7 | INSM |
INSMED Inc
|
900,000 | $147,168,000 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
737,578 | $124,665,433 |
All Filings in DYN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,130,000 | 1,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $101,164,320 | 5,172,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $44,958,100 | 3,554,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $30,378,320 | 3,191,000 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $45,942,000 | 1,950,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $86,314,754 | 2,402,972 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $117,445,120 | 3,328,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $66,006,750 | 2,325,000 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $1,125,000 | 100,000 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $6,912,000 | 600,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,636,000 | 400,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,715,000 | 450,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,915,900 | 570,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,230,000 | 750,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,189,000 | 100,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $812,000 | 50,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,104,000 | 100,000 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||